Ujwala Mahatme's Net Worth
$0
Who is Ujwala Mahatme?
Ujwala Mahatme does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Summit Therapeutics Inc..
SEC CIK
Ujwala Mahatme's CIK is 0001823894
Past Insider Trading and Trends
2022 was Ujwala Mahatme's most active year for acquiring shares with 2 total transactions. Ujwala Mahatme's most active month to acquire stocks was the month of December. 2023 saw Ujwala Mahatme paying a total of $67,635.00 for 75,500 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Summit Therapeutics Inc. (SMMT) Snapshot price: $4.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||